Acclarent

company

About

Acclarent is a medical device company that develops new technologies to treat patients suffering from ENT disorders.

  • 251 - 500

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$26M
Industries
Biotechnology,Health Care,Medical
Founded date
Jun 1, 2004
Number Of Employee
251 - 500
Operating Status
Active

Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients.

Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.

Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$86M
Acclarent has raised a total of $86M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2009 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 12, 2009 Series Unknown $26M 1 Detail
Apr 23, 2007 Series C $35M 1 Detail
Dec 20, 2005 Series B $25M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Acclarent is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series Unknown